17-43125443-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000471181.7(BRCA1):​c.-192T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 362,728 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0047 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 2 hom. )

Consequence

BRCA1
ENST00000471181.7 5_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel B:10

Conservation

PhyloP100: 0.326

Publications

3 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
NBR2 (HGNC:20691): (neighbor of BRCA1 lncRNA 2) This gene was identified by its close proximity on chromosome 17 to tumor suppressor gene BRCA1. Experimental evidence indicates that the two genes share a bi-directional promoter. Transcription for either gene is controlled individually by distinct transcriptional repressor factors. A short (112 amino acid) open reading frame is observed which includes a region derived from a LINE1 element. A strong Kozak signal is not observed for the putative ORF and the stop codon is more than 55 nucleotides upstream of the last splice site for the transcript, suggesting that the transcript is subject to nonsense-mediated decay. Therefore, this gene does not appear to encode a protein. Glucose starvation induces the expression of this gene and the long non-coding RNA transcribed by it functions with AMP-activated protein kinase in mediating the energy stress response. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 17-43125443-A-G is Benign according to our data. Variant chr17-43125443-A-G is described in ClinVar as Benign. ClinVar VariationId is 209579.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00465 (709/152310) while in subpopulation AFR AF = 0.0158 (655/41568). AF 95% confidence interval is 0.0148. There are 10 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000471181.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_001408458.1
c.-61-9664T>C
intron
N/ANP_001395387.1B4DES0
BRCA1
NM_007294.4
MANE Select
c.-192T>C
upstream_gene
N/ANP_009225.1P38398-1
BRCA1
NM_001407581.1
c.-192T>C
upstream_gene
N/ANP_001394510.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000471181.7
TSL:1
c.-192T>C
5_prime_UTR
Exon 1 of 24ENSP00000418960.2P38398-7
BRCA1
ENST00000494123.6
TSL:1
c.-186T>C
5_prime_UTR
Exon 1 of 23ENSP00000419103.2P38398-1
BRCA1
ENST00000468300.5
TSL:1
c.-186T>C
5_prime_UTR
Exon 1 of 22ENSP00000417148.1P38398-6

Frequencies

GnomAD3 genomes
AF:
0.00455
AC:
693
AN:
152192
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0154
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00239
GnomAD4 exome
AF:
0.000499
AC:
105
AN:
210418
Hom.:
2
Cov.:
0
AF XY:
0.000430
AC XY:
50
AN XY:
116148
show subpopulations
African (AFR)
AF:
0.0131
AC:
73
AN:
5558
American (AMR)
AF:
0.00132
AC:
18
AN:
13614
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
5056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8216
South Asian (SAS)
AF:
0.0000669
AC:
3
AN:
44830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9006
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
700
European-Non Finnish (NFE)
AF:
0.0000176
AC:
2
AN:
113480
Other (OTH)
AF:
0.000904
AC:
9
AN:
9958
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00465
AC:
709
AN:
152310
Hom.:
10
Cov.:
32
AF XY:
0.00446
AC XY:
332
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0158
AC:
655
AN:
41568
American (AMR)
AF:
0.00294
AC:
45
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00334
Hom.:
2
Bravo
AF:
0.00520
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
2
Breast-ovarian cancer, familial, susceptibility to, 1 (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.5
DANN
Benign
0.53
PhyloP100
0.33
PromoterAI
-0.11
Neutral
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113323025; hg19: chr17-41277460; API